CV Sciences (CVSI) EBT (2011 - 2026)

CV Sciences has disclosed EBT across 16 years of filings, most recently posting -$643000.0 for Q1 2026.

• EBT for Q1 2026 came in at -$643000.0, down 530.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$908000.0 (up 51.75% YoY), and the FY2025 annual result was -$367000.0, up 84.72% from the prior year.
• EBT came in at -$643000.0 for Q1 2026 at CV Sciences, down from $378000.0 in the prior quarter.
• In the past five years, EBT ranged from a high of $5.7 million in Q1 2023 to a low of -$4.0 million in Q4 2023.
• The 5-year median for EBT is -$622000.0 (2024), against an average of -$646411.8.
• Across the five-year window, EBT tumbled 2477.5% in 2022 and soared 476.63% in 2023, its largest moves.
• CV Sciences' EBT stood at -$2.4 million in 2022, then plunged by 69.01% to -$4.0 million in 2023, then jumped by 81.46% to -$740000.0 in 2024, then soared by 151.08% to $378000.0 in 2025, then plunged by 270.11% to -$643000.0 in 2026.
• The last three EBT figures came in at -$643000.0 (Q1 2026), $378000.0 (Q4 2025), and -$382000.0 (Q3 2025), per Business Quant data.